Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Yuwono Tjota

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Applied Laboratory Medicine|January 3, 2024
Clinical Utility and Benefits of Comprehensive Genomic Profiling in CancerMelissa Yuwono Tjota, Jeremy P Segal, Peng Wang
Histopathology|December 16, 2025
Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular featuresMelissa Yuwono Tjota, Jung Woo Kwon, Pankhuri Wanjari, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 9, 2025
Pan-Cancer Molecular Biomarkers: Practical Considerations for the Surgical PathologistPari Jafari, Megan Forrest, Jeremy Segal, et al.
Virchows Archiv : an International Journal of Pathology|May 11, 2026
Comprehensive analysis of six MED15::TFE3 renal cell carcinomas including two novel solid MED15::TFE3 renal cell carcinomas, highlighting their morphologic, immunohistochemical and molecular differences from their cystic counterpartsJung Woo Kwon, Sarah Mae Lammert, Hayley Zullow, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 7, 2025
Pathogenic POLE-Mutated Endometrial Carcinomas With a Nonultramutated GenomeShruti Srikumar, Nick Evans, Melissa Yuwono Tjota, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Applied Laboratory Medicine|January 3, 2024
Clinical Utility and Benefits of Comprehensive Genomic Profiling in CancerMelissa Yuwono Tjota, Jeremy P Segal, Peng Wang
Histopathology|December 16, 2025
Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular featuresMelissa Yuwono Tjota, Jung Woo Kwon, Pankhuri Wanjari, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 9, 2025
Pan-Cancer Molecular Biomarkers: Practical Considerations for the Surgical PathologistPari Jafari, Megan Forrest, Jeremy Segal, et al.
Virchows Archiv : an International Journal of Pathology|May 11, 2026
Comprehensive analysis of six MED15::TFE3 renal cell carcinomas including two novel solid MED15::TFE3 renal cell carcinomas, highlighting their morphologic, immunohistochemical and molecular differences from their cystic counterpartsJung Woo Kwon, Sarah Mae Lammert, Hayley Zullow, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 7, 2025
Pathogenic POLE-Mutated Endometrial Carcinomas With a Nonultramutated GenomeShruti Srikumar, Nick Evans, Melissa Yuwono Tjota, et al.
Pageof 1